-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$76.33-16.09% Downside
PROCEPT BioRobotics Corporation Frequently Asked Questions
-
What analysts cover PROCEPT BioRobotics Corporation?
PROCEPT BioRobotics Corporation has been rated by research analysts at Truist Financial, Piper Sandler, Wells Fargo in the past 90 days.